A 3-year-old child with Kawasaki disease in the acute phase has fever, bilateral conjunctival injection, strawberry tongue, polymorphous rash, and coronary artery aneurysms on echocardiogram. The parents are concerned about long-term complications. What is the most important nursing intervention to prevent thrombotic complications?
A 4-year-old child diagnosed with Kawasaki disease is hospitalized in the acute phase. The child has fever, bilateral conjunctival injection, strawberry tongue, and polymorphous rash. Echocardiogram reveals coronary artery aneurysms. The parents express anxiety about their child's condition and ask about preventing complications.
1Administer low-dose aspirin as prescribed and monitor for bleeding complications✓ 정답
2Encourage increased fluid intake to maintain adequate hydration
3Apply cool compresses to reduce fever and inflammation
4Restrict physical activity to complete bed rest
해설
Low-dose aspirin is essential to prevent thrombotic complications in Kawasaki disease with coronary aneurysms by inhibiting platelet aggregation. Other options are supportive but do not directly address the primary risk of clot formation.
Core Nursing ExplanationKey Concept Analysis: This question tests the critical nursing intervention for preventing the most serious complication of Kawasaki disease (KD) – coronary artery thrombosis leading to myocardial infarction (MI). The pathophysiology involves a systemic vasculitis that particularly affects medium-sized arteries, especially the coronary arteries. The inflammation can damage the vessel wall, leading to aneurysm formation. During the acute phase, the endothelium is inflamed and platelets are highly activated, creating a high risk for clot formation within these aneurysms. The primary goal of pharmacotherapy is to reduce this thrombotic risk.
Answer Rationale: Key Point! The cornerstone of medical management for Kawasaki disease, especially when coronary artery abnormalities are present, is antiplatelet therapy with aspirin. In the acute febrile phase, high-dose aspirin is used for its anti-inflammatory effect. Once the fever resolves, the dose is reduced to a low, antiplatelet dose (3-5 mg/kg/day) to inhibit platelet aggregation and prevent thrombosis within the aneurysms. This is a long-term therapy that may continue for weeks, months, or even years depending on coronary artery findings. Therefore, administering it as prescribed and monitoring for side effects like bleeding (e.g., bruising, epistaxis, tarry stools) is the nurse's most direct and important intervention to prevent thrombotic complications.
Distractor Analysis:
Watch out for confusion! Option ② (Encourage increased fluid intake) is a supportive measure for any febrile child to prevent dehydration, but it does not directly address the pathophysiological mechanism of platelet aggregation and clot formation in coronary aneurysms.
Option ③ (Apply cool compresses) is a non-pharmacological comfort measure for fever, but it is not a primary intervention for preventing thrombosis. Antipyretics like acetaminophen are typically used alongside aspirin for fever management.
Option ④ (Restrict physical activity to complete bed rest) is incorrect. While strenuous activity may be restricted in children with giant aneurysms to reduce myocardial oxygen demand, complete bed rest is not standard. Most children can engage in gentle, age-appropriate play. The focus is on medication to prevent clots, not immobilization.
Related Concepts: Kawasaki disease management is two-fold: 1) Acute phase: High-dose aspirin + Intravenous Immunoglobulin (IVIG) to reduce inflammation and prevent aneurysm formation. 2) Convalescent/subacute phase: Low-dose aspirin for antiplatelet effect. For children with giant aneurysms or a history of thrombosis, additional anticoagulants (e.g., warfarin, clopidogrel) may be added. Long-term cardiac follow-up with serial echocardiograms is mandatory.
Concept Summary
Phase
Goal
Key Medication
Nursing Focus
Acute (Fever present)
Reduce inflammation, prevent aneurysm formation
High-dose Aspirin, IVIG
IVIG infusion monitoring, fever management, assess for IVIG adverse reactions
Convalescent (Fever resolved)
Prevent coronary thrombosis
Low-dose Aspirin (antiplatelet)
Administer as ordered, educate on bleeding precautions, ensure adherence
Long-term (With aneurysms)
Monitor cardiac status, prevent MI
Low-dose Aspirin ± other anticoagulants
Schedule follow-up echocardiograms, educate on signs of MI (chest pain, vomiting), activity guidance
Anatomy, Physiology & Pharmacology PointsPathophysiology: KD causes panvasculitis (inflammation of all three layers of the artery wall). In the coronary arteries, this weakens the wall, leading to dilation (aneurysm). Turbulent blood flow in the aneurysm promotes platelet activation and adhesion, forming a thrombus that can occlude the vessel.
Pharmacology: Aspirin irreversibly inhibits the enzyme cyclooxygenase-1 (COX-1) in platelets, preventing the synthesis of thromboxane A2, a potent promoter of platelet aggregation. This antiplatelet effect lasts for the lifespan of the platelet (7-10 days).
Memory TipsAcronym for KD Diagnostic Criteria (FEBRILE): Fever (≥5 days), Eyes (conjunctival injection), Bulbar conjunctivae (non-purulent), Rash (polymorphous), Internal oral changes (red lips/strawberry tongue), Lymphadenopathy (cervical, >1.5 cm), Extremities (red palms/soles, later peeling). Need 4 of these + fever.
Drug Phases: Think "HI-LO" for aspirin: HIgh dose in acute phase for Inflammation, LOw dose later to prevent cLOts.
High-Frequency NCLEX Topics
NCLEX loves to test the priority intervention for preventing complications. For Kawasaki disease, the answer will almost always involve aspirin administration and monitoring. Be ready to distinguish between the high-dose (anti-inflammatory) and low-dose (antiplatelet) indications. Also, know that IVIG is given in the acute phase to reduce inflammation and is a single infusion.
Watch Out for Question Variations!
* Instead of asking for the nursing intervention, a question might ask: "The nurse is teaching parents of a child with Kawasaki disease about long-term aspirin therapy. Which statement by a parent indicates understanding?" Correct response would relate to recognizing bleeding signs or not giving other NSAIDs.
* A question could present a child post-IVIG infusion and ask for priority assessment (e.g., for signs of fluid overload or anaphylaxis).
* A question might test knowledge of when to switch from high-dose to low-dose aspirin (typically after fever has been resolved for 48-72 hours).
Nursing Clinical Practice GuideClinical Scenario: You are caring for Liam, a 3-year-old admitted with Kawasaki disease. He received IVIG 48 hours ago, and his fever has now resolved. An echocardiogram shows small coronary artery aneurysms. The physician has changed his aspirin order from high-dose to low-dose (antiplatelet dose). His parents are worried and ask, "Why does he still need aspirin if the fever is gone?"
Nursing Intervention Strategy:
1AssessmentBefore administering the first low-dose, assess for any active bleeding (gums, nose, IV site), check platelet count, and review other medications. Assess the parents' understanding and anxiety.
2Education & AdministrationExplain to the parents: "The aspirin now is at a much lower dose. Its job has changed from fighting fever to keeping his blood from forming tiny clots inside the stretched parts of his heart arteries. We must give this every day as directed to protect his heart." Administer the dose with food or milk to minimize GI upset.
3Monitoring & EvaluationTeach parents to monitor for signs of bleeding (easy bruising, bloody noses, black/tarry stools) and signs of heart problems in a young child (unexplained fussiness, vomiting, pallor, sweating). Emphasize the importance of keeping all follow-up cardiology appointments for repeat echocardiograms. Evaluate understanding by asking them to explain back the purpose of the medicine and warning signs.
Nursing Procedure & Medication FlowAspirin Administration in KD:
* Verify Order: Confirm dose (mg/kg/day) and frequency. Know if it's high-dose (80-100 mg/kg/day in divided doses) or low-dose (3-5 mg/kg/day once daily).
* Assessment: Check for aspirin allergy (rare), history of Reye's syndrome (contraindicated with active viral illness like flu/chickenpox), and current signs of bleeding.
* Administration: Give with food or a full glass of water/ milk to reduce gastric irritation. Use an oral syringe for accurate pediatric dosing.
* Patient/Family Education:
* Do not use other over-the-counter NSAIDs (e.g., ibuprofen) unless directed by the cardiologist, as they can interfere with aspirin's antiplatelet effect.
* Inform all healthcare providers (including dentists) that the child is on aspirin.
* For fever or pain while on low-dose aspirin, use acetaminophen as it does not affect platelet function.
* Report any signs of influenza or chickenpox to the doctor immediately, as aspirin may need to be temporarily held.
A Word from Your Senior Nurse
"Kawasaki disease is one of those pediatric conditions where your nursing vigilance makes a lifelong difference. That low-dose aspirin bottle on the kitchen counter isn't just a pill; it's a shield protecting a child's coronary arteries for years to come. Your ability to clearly explain the 'why' behind the medication transforms parental anxiety into empowered partnership. In clinical practice, always double-check the aspirin dose during care transitions – mixing up high and low doses is a serious medication error. On the NCLEX, when you see 'Kawasaki' and 'coronary aneurysm,' your mind should immediately go to 'antiplatelet therapy' and 'bleeding precautions.' Think of the big picture: you're not just giving a drug; you're preventing a heart attack in a toddler."
Kawasaki Disease — An acute systemic vasculitis of unknown etiology, primarily affecting medium-sized arteries (especially coronary arteries) in young children, characterized by fever and specific clinical criteria.
Coronary Artery Aneurysm — A localized dilation or ballooning of a coronary artery wall, a serious complication of Kawasaki disease that increases the risk of thrombosis, stenosis, and myocardial infarction.
Aspirin (Anti-platelet dose) — Low-dose aspirin (3-5 mg/kg/day) used in the convalescent phase of Kawasaki disease to irreversibly inhibit platelet aggregation, thereby preventing thrombus formation within coronary artery aneurysms.
Intravenous Immunoglobulin — A blood product containing pooled antibodies, given as a single high-dose infusion in the acute phase of Kawasaki disease to reduce systemic inflammation and the risk of coronary artery aneurysm formation.
Vasculitis — Inflammation of the blood vessel walls, which in Kawasaki disease leads to endothelial damage, weakening of the arterial wall, and potential for aneurysm formation and thrombosis.